NCT02515149

Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya

Randomized Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiretroviral Therapy Initiation Among HIV Infected Patients in Rural Western Kenya

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 770 (actual)
• Sponsor: Centers for Disease Control and Prevention · Federal
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Randomised Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiretroviral Therapy Initiation among HIV Infected Patients in Rural Western Kenya.

Conditions

• HIV

Interventions

Type	Name	Description
DEVICE	Point of care CD4 device (Alere PIMA)	for persons testing + with home-based HIV testing using Kenya's two rapid test algorithm, intervention arm participants received point of care CD4 testing followed by counseling on results which included their treatment eligibility

Timeline

• Start date: 2013-07-01
• Primary completion: 2014-09-01
• Completion: 2014-12-01
• First posted: 2015-08-04
• Last updated: 2025-04-08

Locations

1 site across 1 country: Kenya